HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Limited Brands

This article was originally published in The Rose Sheet

Executive Summary

Third quarter sales were flat at $1.89 bil. and comp store sales declined 3% in the period, impacted by weakness in the apparel division, company reports Nov. 17. Firm recorded a net loss of $12.3 mil., Limited Brands adds. Company recently discussed efforts aimed at boosting the performance of its Victoria's Secret Beauty and Bath & Body Works divisions. VSB will introduce its premiere ad campaign and seek to attract retailer's lingerie customers, while B&BW said it intends to scale back its launch program and focus on segmentation of its channels and brand mix (1"The Rose Sheet" Nov. 14, 2005, p. 4 and 2"The Rose Sheet" Nov. 14, 2005, p. 3)...

You may also be interested in...



Victoria’s Secret Beauty Premiere Print, TV Ads Will Debut In December

Victoria's Secret Beauty is seeking to double its $900 mil. retail business by stepping up strategic marketing efforts, launching new products and restaging existing offerings, as well as tapping into the company's lingerie customer base, VSB President and GMM Christine Beauchamp said during Limited Brands' annual investor update meeting Nov. 7-8 in Columbus, Ohio

B&BW Plans To Launch “Expert” Hair Care Line In 2006

Bath & Body Works will re-enter the hair care category in a meaningful way in mid-2006 with the launch of a "major expert brand," CEO Neil Fiske said during the Limited Brands annual investor update meeting Nov. 7-8 in Columbus, Ohio

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel